Untargeted metabolomics-assisted comparative cytochrome P450-dependent metabolism of fenbendazole in human and dog liver microsomes

References

• Adusumilli R, Mallick P. 2017. Data conversion with ProteoWizard msConvert. Methods Mol Biol. 1550:339–368.
   PubMedGoogle Scholar
• Baeder C, Bahr H, Christ O, Duwel D, Kellner HM, Kirsch R, Loewe H, Schultes E, Schutz E, Westen H. 1974. Fenbendazole: a new, highly effective anthelmintic. Experientia. 30(7):753–754.
   PubMedGoogle Scholar
• Barker SA, Hsieh LC, McDowell TR, Short CR. 1987. Qualitative and quantitative analysis of the anthelmintic fenbendazole and its metabolites in biological matrices by direct exposure probe mass spectrometry. Biomed Environ Mass Spectrom. 14(4):161–165.
   PubMedGoogle Scholar
• Blasco H, Błaszczyński J, Billaut JC, Nadal-Desbarats L, Pradat PF, Devos D, Moreau C, Andres CR, Emond P, Corcia P, et al. 2015. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis. J Biomed Inform. 53:291–299.
   PubMed Web of Science ®Google Scholar
• Bro R, Smilde AK. 2014. Principal component analysis. Anal Methods. 6(9):2812–2831.
   Web of Science ®Google Scholar
• Campbell WC. 1990. Benzimidazoles: veterinary uses. Parasitol Today. 6(4):130–133.
   PubMedGoogle Scholar
• Chen C, Gonzalez FJ, Idle JR. 2007. LC-MS-based metabolomics in drug metabolism. Drug Metab Rev. 39(2–3):581–597.
   PubMed Web of Science ®Google Scholar
• Ciuca L, Pepe P, Bosco A, Caccio SM, Maurelli MP, Sannella AR, Vismarra A, Cringoli G, Kramer L, Rinaldi L, et al. 2021. Effectiveness of fenbendazole and metronidazole against giardia infection in dogs monitored for 50-days in home-conditions. Front Vet Sci. 8:626424.
   PubMed Web of Science ®Google Scholar
• Dawson PJ, Gutteridge WE, Gull K. 1984. A comparison of the interaction of anthelmintic benzimidazoles with tubulin isolated from mammalian tissue and the parasitic nematode Ascaridia galli. Biochem Pharmacol. 33(7):1069–1074.
   PubMed Web of Science ®Google Scholar
• Defossez E, Bourquin J, von Reuss S, Rasmann S, Glauser G. 2023. Eight key rules for successful data-dependent acquisition in mass spectrometry-based metabolomics. Mass Spectrom Rev. 42(1):131–143.
   PubMed Web of Science ®Google Scholar
• Dogra N, Kumar A, Mukhopadhyay T. 2018. Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways. Sci Rep. 8(1):11926.
   PubMedGoogle Scholar
• Düwel D. 1977. Fenbendazole. II. Biological properties and activity. Pestic Sci. 8(5):550–555.
   Google Scholar
• Duan Q, Liu Y, Booth CJ, Rockwell S. 2012. Use of fenbendazole-containing therapeutic diets for mice in experimental cancer therapy studies. J Am Assoc Lab Anim Sci. 51(2):224–230.
   PubMed Web of Science ®Google Scholar
• FDA. 2020. Safety testing of drug metabolites guidance for industry. U.S. Department of Health and Human Services. U.S. Food and Drug Administration.
   Google Scholar
• Florio R, Carradori S, Veschi S, Brocco D, Di Genni T, Cirilli R, Casulli A, Cama A, De Lellis L. 2021. Screening of benzimidazole-based anthelmintics and their enantiomers as repurposed drug candidates in cancer therapy. Pharmaceuticals (Basel). 14(4):372.
   PubMedGoogle Scholar
• Gao P, Dang CV, Watson J. 2008. Unexpected antitumorigenic effect of fenbendazole when combined with supplementary vitamins. J Am Assoc Lab Anim Sci. 47(6):37–40.
   PubMed Web of Science ®Google Scholar
• Gokbulut C, Akar F, McKellar QA. 2006. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys. Vet J. 172(1):166–172.
   PubMed Web of Science ®Google Scholar
• Gokbulut C, Bilgili A, Hanedan B, McKellar QA. 2007. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs. Vet Parasitol. 148(3-4):279–287.
   PubMed Web of Science ®Google Scholar
• Gottschall DW, Theodorides VJ, Wang R. 1990. The metabolism of benzimidazole anthelmintics. Parasitol Today. 6(4):115–124.
   PubMedGoogle Scholar
• Gromski PS, Muhamadali H, Ellis DI, Xu Y, Correa E, Turner ML, Goodacre R. 2015. A tutorial review: metabolomics and partial least squares-discriminant analysis–a marriage of convenience or a shotgun wedding. Anal Chim Acta. 879:10–23.
   PubMed Web of Science ®Google Scholar
• He C, Wan H. 2018. Drug metabolism and metabolite safety assessment in drug discovery and development. Expert Opin Drug Metab Toxicol. 14(10):1071–1085.
   PubMed Web of Science ®Google Scholar
• Itoh N, Kanai K, Hori Y, Nakao R, Hoshi F, Higuchi S. 2009. Fenbendazole treatment of dogs with naturally acquired Strongyloides stercoralis infection. Vet Rec. 164(18):559–560.
   PubMed Web of Science ®Google Scholar
• Jang J, Lee K, Koh B. 2022. Investigation of benzimidazole anthelmintics as oral anticancer agents. Bulletin Korean Chem Soc. 43(5):750–756.
   Web of Science ®Google Scholar
• Kim HJ, Cho CW, Hwang JT, Son N, Choi JH, Shim GS, Han CK. 2013. LC-MS-based metabolomic analysis of serum and livers from red ginseng-fed rats. J Ginseng Res. 37(3):371–378.
   PubMed Web of Science ®Google Scholar
• Kim JH, Choi WG, Lee S, Lee HS. 2017. Revisiting the metabolism and bioactivation of ketoconazole in human and mouse using liquid chromatography–mass spectrometry-based metabolomics. Int J Mol Sci. 18(3):621.
   Web of Science ®Google Scholar
• Kim JH, Choi WG, Moon JY, Lee JY, Lee S, Lee HS. 2018a. Metabolomics-assisted metabolite profiling of itraconazole in human liver preparations. J Chromatogr B Analyt Technol Biomed Life Sci. 1083:68–74.
   PubMed Web of Science ®Google Scholar
• Kim JH, Jo JH, Seo KA, Hwang H, Lee HS, Lee S. 2018b. Non-targeted metabolomics-guided sildenafil metabolism study in human liver microsomes. J Chromatogr B Analyt Technol Biomed Life Sci. 1072:86–93.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kong TY, Moon JY, Choi KH, Cho YY, Kang HC, Lee JY, Lee HS. 2018c. Targeted and non-targeted metabolite identification of MAM-2201 in human, mouse, and rat hepatocytes. Drug Test Anal. 10(8):1328–1335.
   Web of Science ®Google Scholar
• Kitzman JV, Holley JH, Huber WG, Koritz GD, Davis LE, Neff-Davis CA, Bevill RF, Short CR, Barker SA, Hsieh LC. 1990. Pharmacokinetics and metabolism of fenbendazole in channel catfish. Vet Res Commun. 14(3):217–226.
   PubMed Web of Science ®Google Scholar
• Kong X, Yang X, Zhou J, Chen S, Li X, Jian F, Deng P, Li W. 2015. Analysis of plasma metabolic biomarkers in the development of 4-nitroquinoline-1-oxide-induced oral carcinogenesis in rats. Oncol Lett. 9(1):283–289.
   PubMed Web of Science ®Google Scholar
• Lacey E. 1988. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int J Parasitol. 18(7):885–936.
   PubMed Web of Science ®Google Scholar
• Laizure SC, Herring V, Hu Z, Witbrodt K, Parker RB. 2013. The role of human carboxylesterases in drug metabolism: have we overlooked their importance? Pharmacotherapy. 33(2):210–222.
   PubMed Web of Science ®Google Scholar
• Landuyt J, Debackere M, Delbeke F, McKellar QA. 1993. A high performance liquid chromatographic method for the determination of febantel and its major metabolites in lamb plasma. Biomed Chromatogr. 7(2):78–81.
   PubMed Web of Science ®Google Scholar
• Lanusse CE, Gascon LH, Prichard RK. 1995. Influence on the antithyroid compound methimazole on the plasma disposition of fenbendazole and oxfendazole in sheep. Res Vet Sci. 58(3):222–226.
   PubMed Web of Science ®Google Scholar
• Le Dare B, Ferron PJ, Allard PM, Clement B, Morel I, Gicquel T. 2020. New insights into quetiapine metabolism using molecular networking. Sci Rep. 10(1):19921.
   PubMed Web of Science ®Google Scholar
• Marriner SE, Bogan JA. 1981. Pharmacokinetics of oxfendazole in sheep. Am J Vet Res. 42(7):1143–1145.
   PubMed Web of Science ®Google Scholar
• Marriner SE, Bogan JA. 1985. Plasma concentrations of fenbendazole and oxfendazole in the horse. Equine Vet J. 17(1):58–61.
   PubMed Web of Science ®Google Scholar
• McKellar QA, Galbraith EA, Baxter P. 1993. Oral absorption and bioavailability of fenbendazole in the dog and the effect of concurrent ingestion of food. J Vet Pharmacol Ther. 16(2):189–198.
   PubMed Web of Science ®Google Scholar
• McKellar QA, Gokbulut C, Muzandu K, Benchaoui H. 2002. Fenbendazole pharmacokinetics, metabolism, and potentiation in horses. Drug Metab Dispos. 30(11):1230–1239.
   PubMed Web of Science ®Google Scholar
• McKellar QA, Harrison P, Galbraith EA, Inglis H. 1990. Pharmacokinetics of fenbendazole in dogs. J Vet Pharmacol Ther. 13(4):386–392.
   PubMed Web of Science ®Google Scholar
• Meyer MR, Maurer HH. 2012. Current applications of high-resolution mass spectrometry in drug metabolism studies. Anal Bioanal Chem. 403(5):1221–1231.
   PubMed Web of Science ®Google Scholar
• Montesissa C, Stracciari JM, Fadini L, Beretta C. 1989. Comparative microsomal oxidation of febantel and its metabolite fenbendazole in various animal species. Xenobiotica. 19(1):97–100.
   PubMed Web of Science ®Google Scholar
• Morovján G, Csokán P, Makranszki L, Abdellah-Nagy EA, Tóth K. 1998. Determination of fenbendazole, praziquantel and pyrantel pamoate in dog plasma by high-performance liquid chromatography. J Chromatogr A. 797(1-2):237–244.
   PubMed Web of Science ®Google Scholar
• Murray M, Hudson AM, Yassa V. 1992. Hepatic microsomal metabolism of the anthelmintic benzimidazole fenbendazole: enhanced inhibition of cytochrome P450 reactions by oxidized metabolites of the drug. Chem Res Toxicol. 5(1):60–66.
   PubMed Web of Science ®Google Scholar
• Ngomuo AJ, Marriner SE, Bogan JA. 1984. The pharmacokinetics of fenbendazole and oxfendazole in cattle. Vet Res Commun. 8(3):187–193.
   PubMed Web of Science ®Google Scholar
• Pang Z, Zhou G, Ewald J, Chang L, Hacariz O, Basu N, Xia J. 2022. Using MetaboAnalyst 5.0 for LC-HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data. Nat Protoc. 17(8):1735–1761.
   PubMed Web of Science ®Google Scholar
• Pluskal T, Castillo S, Villar-Briones A, Oresic M. 2010. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics. 11(1):395.
   PubMed Web of Science ®Google Scholar
• Quinn RA, Nothias LF, Vining O, Meehan M, Esquenazi E, Dorrestein PC. 2017. Molecular networking as a drug discovery, drug metabolism, and precision medicine strategy. Trends Pharmacol Sci. 38(2):143–154.
   PubMed Web of Science ®Google Scholar
• Schadt S, Bister B, Chowdhury SK, Funk C, Hop C, Humphreys WG, Igarashi F, James AD, Kagan M, Khojasteh SC, et al. 2018. A decade in the MIST: learnings from investigations of drug metabolites in drug development under the "metabolites in safety testing" regulatory guidance. Drug Metab Dispos. 46(6):865–878.
   PubMed Web of Science ®Google Scholar
• Schwartz RD, Donoghue AR, Baggs RB, Clark T, Partington C. 2000. Evaluation of the safety of fenbendazole in cats. Am J Vet Res. 61(3):330–332.
   PubMed Web of Science ®Google Scholar
• Shon JC, Shin HS, Seo YK, Yoon YR, Shin H, Liu KH. 2015. Direct infusion MS-based lipid profiling reveals the pharmacological effects of compound K-reinforced ginsenosides in high-fat diet induced obese mice. J Agric Food Chem. 63(11):2919–2929.
   PubMed Web of Science ®Google Scholar
• Short CR, Flory W, Hsieh LC, Barker SA. 1988. The oxidative metabolism of fenbendazole: a comparative study. J Vet Pharmacol Ther. 11(1):50–55.
   PubMed Web of Science ®Google Scholar
• Son DS, Lee ES, Adunyah SE. 2020. The antitumor potentials of benzimidazole anthelmintics as repurposing drugs. Immune Netw. 20(4):e29.
   PubMed Web of Science ®Google Scholar
• Sorensen LK, Hansen H. 1998. Determination of fenbendazole and its metabolites in trout by a high-performance liquid chromatographic method. Analyst. 123(12):2559–2562.
   PubMed Web of Science ®Google Scholar
• Szymańska E, Saccenti E, Smilde AK, Westerhuis JA. 2012. Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies. Metabolomics. 8(S1):3–16.
   PubMedGoogle Scholar
• Traquete F, Luz J, Cordeiro C, Sousa Silva M, Ferreira AEN. 2021. Binary simplification as an effective tool in metabolomics data analysis. Metabolites. 11(11):788.
   PubMed Web of Science ®Google Scholar
• Triba MN, Le Moyec L, Amathieu R, Goossens C, Bouchemal N, Nahon P, Rutledge DN, Savarin P. 2015. PLS/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parameters. Mol Biosyst. 11(1):13–19.
   PubMedGoogle Scholar
• Virkel G, Lifschitz A, Sallovitz J, Pis A, Lanusse C. 2004. Comparative hepatic and extrahepatic enantioselective sulfoxidation of albendazole and fenbendazole in sheep and cattle. Drug Metab Dispos. 32(5):536–544.
   PubMed Web of Science ®Google Scholar
• Vlachou I, Parsonidis P, Mamagkaki A, Bouris I, Papasotiriou I. 2022. Teaching an old dog new tricks: the case of Fenbendazole. Cancer Treat Res Commun. 32:100601.
   PubMedGoogle Scholar
• Wen B, Zhu M. 2015. Applications of mass spectrometry in drug metabolism: 50 years of progress. Drug Metab Rev. 47(1):71–87.
   PubMed Web of Science ®Google Scholar
• Williams ET, Bacon JA, Bender DM, Lowinger JJ, Guo W-K, Ehsani ME, Wang X, Wang H, Qian Y-W, Ruterbories KJ, et al. 2011. Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog, cynomolgus monkey, and human. Drug Metab Dispos. 39(12):2305–2313.
   PubMed Web of Science ®Google Scholar
• Williams ET, Wang H, Wrighton SA, Qian YW, Perkins EJ. 2010. Genomic analysis of the carboxylesterases: identification and classification of novel forms. Mol Phylogenet Evol. 57(1):23–34.
   PubMed Web of Science ®Google Scholar
• Worley B, Powers R. 2013. Multivariate analysis in metabolomics. Curr Metabolomics. 1(1):92–107.
   PubMedGoogle Scholar
• Worley B, Powers R. 2016. PCA as a practical indicator of OPLS-DA model reliability. Curr Metabolomics. 4(2):97–103.
   PubMed Web of Science ®Google Scholar
• Wu Z, Lee D, Joo J, Shin JH, Kang W, Oh S, Lee DY, Lee SJ, Yea SS, Lee HS, et al. 2013. CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems. Antimicrob Agents Chemother. 57(11):5448–5456.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Fukami T, Kurokawa T, Gotoh S, Oda A, Nakajima M. 2018. Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans. Eur J Pharm Sci. 111:167–176.
   PubMed Web of Science ®Google Scholar
• Yu JS, Nothias LF, Wang M, Kim DH, Dorrestein PC, Kang KB, Yoo HH. 2022. Tandem mass spectrometry molecular networking as a powerful and efficient tool for drug metabolism studies. Anal Chem. 94(2):1456–1464.
   PubMed Web of Science ®Google Scholar